bionorthTX debuts region’s growing life sciences industry at BIO 2016
bionorthTX will use the upcoming Biotechnology Innovation Organization’s (BIO) 2016 International Convention in San Francisco, 6-9 June to spotlight the region’s burgeoning life sciences industry and world-class universities.
Founded in 2014 to promote North Texas’s life sciences and healthcare innovation and industry development, bionorthTX will showcase the region’s companies and research institutions to more than 15,000 biotech and pharma leaders from 69 countries.
“To outsiders our region may be known more for the financial market, software, oil & gas and the stockyards than life science and healthcare innovation,” said bionorthTX co-founder and COO Kay Tieman. “Participating in the BIO annual convention will give us an opportunity to show the world’s biotech and pharma professionals we are a leading center of health care and life sciences industry development, which should also drive public and private capital to our members.”
North Texas is home to 1,000 life sciences related companies with more than 26,000 employees focused on therapeutics, diagnostics, devices, clinical research, contract manufacturing and health care IT. The region includes a range of companies from multinational corporations such as Abbot Laboratories, Alcon, Celanese Chemicals, Covance Clinical Research, Essilor, Galderma Laboratories, McKesson Corp., and Smith & Nephew, to emerging companies like Neos Therapeutics, Reata Pharmaceuticals, ZS Pharma and Thermi, to startups. In addition, a critical element of the foundation for life sciences industry development is a strong network of collaborative universities. North Texas’s academic institutions, global leaders in life sciences research, include University of Texas (UT) Southwestern Medical Center, UT’s Arlington and Dallas campuses, along with Baylor Scott & White Health and Research Institute and the University of North Texas Health Science Center in Fort Worth.
“Among our major initiatives,” Tieman said, “is our 2nd annual iC3 Life Science Summit, which last year brought 275 stakeholders together to discuss Innovation, Collaboration, Capital formation and Commercialization (iC3) in North Texas. It will be held on October 26th at UT Arlington and we anticipate 350-400 in attendance.”
Examples of the region’s growing health care industry include the recent expansion of Galderma’s $22 million research and development center, expected to add up to 350 employees, and McKesson’s opening of a new distribution center with 950 employees.
Thermi, a company developing thermistor-regulated energy solutions for aesthetics, dermatology and women's health, also is expanding following its acquisition by Barcelona-based Almirall for $88 million; and Neos Therapeutics, an emerging company developing treatments for attention deficit hyperactivity disorder, held a successful initial public offering in 2015.
“We have an exciting story to tell about North Texas’s vibrant health care and life sciences industries,” Tieman said. “This is a primary objective for bionorthTX and attending BIO 2016 is just a first step.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance